Huddersfield company Paxman launches system to reduce chemotherapy-related nerve damage
Science & Health

Huddersfield company Paxman launches system to reduce chemotherapy-related nerve damage

1 hour ago · Originally published 5 Nov 2026 8/10 Original headline: Paxman's new system aims to reduce risk of lasting nerve damage from chemotherapy
Huddersfield-based Paxman has developed a new device designed to prevent chemotherapy-induced peripheral neuropathy, a condition that can cause long-term pain and numbness for patients. By expanding beyond their established scalp cooling technology, the company aims to provide a new option for managing treatment side effects that currently have few preventative solutions.
Source: Yorkshire Post West Yorkshire
Read the full story

About the AI positivity score

Report this article

Get your regular dose of good news

Follow the best stories on Bluesky or subscribe with your favourite feed reader.

How AI positivity scores work

Scores out of ten are AI estimates of how uplifting a story is, not a measure of accuracy or importance. Different readers may feel differently. Headlines and summaries are AI-written; follow the source link for the original reporting.

How stories are selected